“ptc-therapeutics” Archives

in
Entry Author Date Location
Duchenne Lessons: Advocates For Rare Spinal Disease Have Eyes on FDA 08/26/16 National
Biotech Roundup: Gilead Slump, Celgene Goes Trump, Hemo Data & More 07/29/16 National
Sarepta Stock Down as FDA Seeks More Data from Rival Duchenne Drug 07/14/16 Boston
Two Years After Paying $680M, BioMarin Shelves Duchenne Drug 05/31/16 San Francisco
Sarepta Saga Drags On as FDA Delays Decision on Duchenne Drug 05/25/16 Boston
Near-Term FDA Nod Unlikely For Duchenne Drug After Negative Vote 04/25/16 Boston
East Coast Biotech Roundup: Harvard’s Haul, Patent Fights, Padlock & More 03/24/16 Boston
Startups Begin to Emerge From NYU’s “Virtual” Biotech Factory 03/17/16 New York
East Coast Biotech Roundup: Ribon, Syndax, Aldeyra & More 03/03/16 Boston
Déjà Vu for PTC as FDA Declines to Consider Duchenne Drug App 02/23/16 New York
Safety Issues Spur Foundation-Backed Akashi to Suspend Duchenne Trial 01/26/16 Boston
At Duchenne Panel, Parents Plead With Experts, FDA Decision Looms 11/24/15 San Francisco
East Coast Biotech Roundup: Zafgen, Decibel, Voyager & More 10/16/15 Boston
PTC Unveils Mixed Duchenne Results, But Plots an FDA Filing 10/15/15 New York
After Shift to Duchenne and Cholesterol Drugs, Catabasis Files For IPO 05/14/15 Boston
Dallas’ AveXis Gets $10M to Bring Gene Therapy to Rare Spinal Disorder 01/20/15 Texas
BioMarin Gambles $840M on Prosensa’s Duchenne Drug 11/24/14 San Francisco
East Coast Biotech Roundup: Bristol, PTC, Ophthotech, & More 05/27/14 Boston
Navigating JOBS, Wrangling Investors: A Biotech CFO Roundtable 05/27/14 National
EU Reverses Course on PTC Drug, Shares Boom 05/23/14 New York
East Coast Biotech Roundup: Enanta, NY Disruptors, Repligen, & More 01/24/14 Boston
Sarepta Shares Crumble As FDA Calls New Drug Application “Premature” 11/12/13 Boston
Sarepta to Seek FDA Approval For Duchenne Muscular Dystrophy Drug 07/24/13 Boston
NY Editor’s Picks: Xconomy Stories That Got This City Talking in Q2 07/03/13 New York
East Coast Life Sciences Roundup: IPO Madness, Amicus, & More 06/21/13 Boston
PTC Therapeutics IPO Raises $125M Despite Checkered Past 06/20/13 New York
East Coast Life Sciences Roundup: ASCO, Follica, Aveo, & More 06/07/13 Boston
East Coast Life Sciences Roundup: Merck, Celgene, PTC, Cerulean 03/08/13 Boston
Sarepta Drug Helps Boys With Duchenne to Walk; Shares Boom 10/03/12 Boston
Vertex’s Big Day Felt Like Moon Landing, Seattle Researcher Says 02/01/12 Boston
Page 2 of 3 « previous page · next page »